Envoy Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Envoy Medical, Inc. on September 6, 2024. The filing announces the date and logistics for the Company's Annual Meeting of Stockholders. The Company is an emerging growth company incorporated in Delaware.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters regarding the upcoming shareholder meeting.
Material Changes
There are no material financial changes reported in this filing. The primary event is the scheduling of the Annual Meeting, noting that the Company did not hold an annual meeting in 2023.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: Thursday, November 14, 2024, at 3:00 p.m. Central time.
- Location: Delta Hotels Minneapolis Northeast, 1330 Industrial Blvd NE, Minneapolis, Minnesota.
- Record Date: September 16, 2024 (holders of record as of this date are entitled to vote).
- Director Nominations/Proposals (Advance Notice): Written notice must be received by the Corporate Secretary by September 16, 2024.
- Rule 14a-8 Proposals: Proposals for inclusion in the proxy statement must be received by September 20, 2024.
Key Facts for Investor Verification
- Verify the record date of September 16, 2024, to confirm voting eligibility.
- Confirm the deadline of September 16, 2024, for submitting advance notice director nominations.
- Confirm the deadline of September 20, 2024, for submitting Rule 14a-8 stockholder proposals.
- Review the upcoming proxy statement for details on specific matters to be voted upon.